153 related articles for article (PubMed ID: 38412308)
1. Genomic testing and patient rights.
Jones CM; Karp J; Davis DS
J Natl Cancer Inst; 2024 May; 116(5):771-772. PubMed ID: 38412308
[No Abstract] [Full Text] [Related]
2. Direct-to-consumer genetic testing: the need to get retail genomics right.
Schickedanz AD; Herdman RC
Clin Pharmacol Ther; 2009 Jul; 86(1):17-20. PubMed ID: 19536118
[No Abstract] [Full Text] [Related]
3. A consumer charter for genomic services.
Ledley F
Nat Biotechnol; 2002 Aug; 20(8):767. PubMed ID: 12147991
[No Abstract] [Full Text] [Related]
4. The right roadmap for personalized tests.
Bourzac K
Cancer Discov; 2012 Jun; 2(6):478. PubMed ID: 22684442
[No Abstract] [Full Text] [Related]
5. American College of Medical Genetics and Genomics: standards and guidelines for documenting suspected consanguinity as an incidental finding of genomic testing.
Rehder CW; David KL; Hirsch B; Toriello HV; Wilson CM; Kearney HM
Genet Med; 2013 Feb; 15(2):150-2. PubMed ID: 23328890
[TBL] [Abstract][Full Text] [Related]
6. Professional responsibilities regarding the provision, publication, and dissemination of patient phenotypes in the context of clinical genetic and genomic testing: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
Bush LW; Beck AE; Biesecker LG; Evans JP; Hamosh A; Holm IA; Martin CL; Richards CS; Rehm HL
Genet Med; 2018 Feb; 20(2):169-171. PubMed ID: 29323668
[TBL] [Abstract][Full Text] [Related]
7. Solving unsolved rare neurological diseases-a Solve-RD viewpoint.
Schüle R; Timmann D; Erasmus CE; Reichbauer J; Wayand M; ; van de Warrenburg B; Schöls L; Wilke C; Bevot A; Zuchner S; Beltran S; Laurie S; Matalonga L; Graessner H; Synofzik M;
Eur J Hum Genet; 2021 Sep; 29(9):1332-1336. PubMed ID: 33972714
[No Abstract] [Full Text] [Related]
8. Genetic screening: birthright or earned with age?
Mollison L; Berg JS
Expert Rev Mol Diagn; 2017 Aug; 17(8):735-738. PubMed ID: 28641021
[No Abstract] [Full Text] [Related]
9. Genomics for paediatricians: promises and pitfalls.
Hammond CL; Willoughby JM; Parker MJ
Arch Dis Child; 2018 Sep; 103(9):895-900. PubMed ID: 29574410
[TBL] [Abstract][Full Text] [Related]
10. Clinical genomic testing: getting it right.
Douglas PS; Ginsburg GS
J Cardiovasc Transl Res; 2008 Mar; 1(1):17-20. PubMed ID: 20559953
[No Abstract] [Full Text] [Related]
11. The Clinical Autopsy and Genomic Testing.
Sklar J
Am J Pathol; 2019 Sep; 189(9):1682-1685. PubMed ID: 31199923
[TBL] [Abstract][Full Text] [Related]
12. Harnessing the Diagnostic Power of Genomic Technology: Genomic technology may shed years off the diagnostic process.
Am J Med Genet A; 2019 Nov; 179(11):2164-2165. PubMed ID: 31603602
[No Abstract] [Full Text] [Related]
13. [Failure to screen Down syndrome].
Metsälä T
Duodecim; 2004; 120(3):352; author reply 355-6. PubMed ID: 15061014
[No Abstract] [Full Text] [Related]
14. Advances in genomic testing.
Donoghue S; Downie L; Stutterd C
Aust Fam Physician; 2017; 46(4):200-205. PubMed ID: 28376572
[TBL] [Abstract][Full Text] [Related]
15. Genomic testing: a struggle for oncologists.
Hede K
J Natl Cancer Inst; 2014 Jun; 106(6):dju172. PubMed ID: 24907388
[No Abstract] [Full Text] [Related]
16. Laboratory and clinical genomic data sharing is crucial to improving genetic health care: a position statement of the American College of Medical Genetics and Genomics.
Acmg Board Of Directors
Genet Med; 2017 Jul; 19(7):721-722. PubMed ID: 28055021
[TBL] [Abstract][Full Text] [Related]
17. Genetic and genomic testing in clinical practice: what you need to know.
Beery TA
Rehabil Nurs; 2014; 39(2):70-5. PubMed ID: 24038079
[TBL] [Abstract][Full Text] [Related]
18. The Japanese Society of Pathology Practical Guidelines on the handling of pathological tissue samples for cancer genomic medicine.
Hatanaka Y; Kuwata T; Morii E; Kanai Y; Ichikawa H; Kubo T; Hatanaka KC; Sakai K; Nishio K; Fujii S; Okamoto W; Yoshino T; Ochiai A; Oda Y
Pathol Int; 2021 Nov; 71(11):725-740. PubMed ID: 34614280
[TBL] [Abstract][Full Text] [Related]
19. Personalized medicine: a perk of privilege?
Griggs JJ
Clin Pharmacol Ther; 2009 Jul; 86(1):21-3. PubMed ID: 19536119
[TBL] [Abstract][Full Text] [Related]
20. Assessing the safety of nanomaterials by genomic approach could be another alternative.
Lee TL; Chan WY; Rennert OM
ACS Nano; 2009 Dec; 3(12):3830; author reply 3830-1. PubMed ID: 20025301
[No Abstract] [Full Text] [Related]
[Next] [New Search]
